metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Secondary Attack Rate of Hepatitis C Virus (HCV)
Journal Information
Vol. 29. Issue S2.
Abstracts Asociación Mexicana del Hígado (AMH) 2023
(February 2024)
Share
Share
Download PDF
More article options
Vol. 29. Issue S2.
Abstracts Asociación Mexicana del Hígado (AMH) 2023
(February 2024)
Full text access
Secondary Attack Rate of Hepatitis C Virus (HCV)
Visits
339
José A. Cisneros-Rodríguez1, Miguel E. Manuel Moreno-Miceli2, Ana D. Cano-Contreras3, Bertha R. De La Paz-Ibarra3, Jessica C. Carrillo-Navarro3, Judith A. Sánchez Hernández3, José A. Franco-Rico4
1 Medicina Interna, UMAE Hospital de Oncología CMN Siglo XXI, Instituto Mexicano del Seguro Social, México
2 Infectología, UMAE Hospital De Especialidades No. 14 CMN “Adolfo Ruiz Cortines”, Instituto Mexicano del Seguro Social, México
3 Gastroenterología, UMAE Hospital De Especialidades No. 14 CMN “Adolfo Ruiz Cortines”, Instituto Mexicano del Seguro Social, México
4 Centro de Documentación en Salud, UMAE Hospital de Pediatría CMN Siglo XXI, Instituto Mexicano del Seguro Social, México
This item has received
Article information
Abstract
Full Text
Download PDF
Statistics
Tables (2)
Table 1. Frequency Distribution of Risk Factors in first-degree relatives diagnosed with Hepatitis C Virus (HCV) infection.
Table 2. Calculation of attack rate, secondary attack rate, and R0 in first-degree relatives diagnosed with Hepatitis C Virus (HCV) infection.
Show moreShow less
Special issue
This article is part of special issue:
Vol. 29. Issue S2

Abstracts Asociación Mexicana del Hígado (AMH) 2023

More info
Introduction and Objectives

The transmission routes of Hepatitis C Virus (HCV) are categorized as horizontal and vertical. The former includes sexual contact, parenteral exposure, and intrafamilial transmission, while the latter pertains to mother-to-child transmission. Although extensive literature has documented the parenteral route and sexual contact, there is a paucity of studies examining intrafamilial transmission within the Mexican population. This study aims to determine the rate of horizontal viral transmission among first-degree relatives of patients diagnosed with HCV infection who received treatment at Hospital de Especialidades No. 14, Centro Medico Nacional "Adolfo Ruiz Cortines."

Materials and Methods

The study design is observational, descriptive, and retrospective. Patient records from outpatient clinics were scrutinized for the period spanning January 2018 to January 2022. Clinical and epidemiological characteristics, risk factors obtained from medical histories, and laboratory results (including positive HCV viral load and HCV serum PCR test) were evaluated to classify cohorts. Informed consent was obtained from all patients. The research work was registered and approved by the Local Research Committee (R-2022-3001-088).

Results

A total of 129 patients were analyzed, with an average age of 39.56 years. Female gender predominated among 68 patients (52.7%), and 29 patients (22.5%) acquired HCV infection. The primary risk factors identified were Systemic Arterial Hypertension (RR: 7.47, 95% CI: 2.951-18.914, p<0.05), Type 2 Diabetes Mellitus (RR: 16.125, 95% CI: 5.985-43.441, p<0.05), and Chronic Kidney Disease (RR: 10.795, 95% CI: 3.736-31.188, p<0.05) (Table 1). Only two patients (6.89%) were classified as having chronic infection based on measured viral load. All patients received Direct-Acting Antiviral treatment, resulting in sustained viral response at three months post-treatment completion. The primary attack rate was 22.48%, the secondary attack rate was 412.5%, and the R0 was 1,492,953 (Table 2).

Conclusions

The study demonstrated that first-degree relatives with comorbidities are at a higher risk of contracting HCV infection. The study's findings also revealed that the prevalence of HCV infection is higher than the reported rate in the general population. These results highlight the importance of targeted screening programs, especially in high-risk populations with comorbidities, to identify and treat HCV infections promptly. Such efforts will contribute significantly to the international goals for eradicating this virus and preventing further transmission. Moreover, the study's findings underscore the need for increased awareness and preventive measures to reduce the impact of HCV within the Mexican population.

Full Text

Ethical statement

The protocol was registered and approved by the Ethics Committee. The identity of the patients is protected. Consentment was obtained.

Declaration of interests

None

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Table 1.

Frequency Distribution of Risk Factors in first-degree relatives diagnosed with Hepatitis C Virus (HCV) infection.

Risk FactorsHepatitis C Virus InfectionpRRLower 95% CIUpper 95% CI
No  Yes 
Tobacco Use DisorderNegative  90  24  0.281.8750.5856.006
Positive  10 
AlcoholismNegative  87  22  0.142.1290.7595.791
Positive  13 
HypertensionNegative  74  <0.057.4712.95118.914
Positive  26  21 
Diabetes Mellitus, Type 1Negative  99  29  0.580.7730.7040.849
Positive 
Diabetes Mellitus, Type 2Negative  86  <0.0516.1255.98543.441
Positive  14  21 
Pulmonary Disease, Chronic ObstructiveNegative  97  26  0.093.7310.71119.578
Positive 
Renal Insufficiency, ChronicNegative  93  16  <0.0510.7953.73631.188
Positive  13 
ImmunocompromisedNegative  100  23  <0.050.1870.1290.27
Positive 

Table 2.

Calculation of attack rate, secondary attack rate, and R0 in first-degree relatives diagnosed with Hepatitis C Virus (HCV) infection.

Rate 
Attack Rate  22.48 
Secondary attack rate  412.50 
R0  1,492,953 

Number of new cases of the disease: 29

Number of infectious contacts: 129

Total number of individuals exposed to an infection, outbreak, or epidemic: 29

Number of individuals who have developed the disease: 129

Total number of susceptible individuals exposed:169

Transmissibility: 161

Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.aohep.2024.101397
No mostrar más